SCHEMBL4741712

SCHEMBL4741712

O=C(NCC1CCCN1)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PREP P48147 2/20 0.48
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
GAA P10253 2/20 0.47
HTT P42858 1/20 0.47
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.45
EPHX1 P07099 1/20 0.45
CCKBR P32239 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8246719 1.00 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL4154315 1.00 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
Hydrochloric Acid SCHEMBL4741718 0.99 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
Hydrochloric Acid SCHEMBL4741714 0.99 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL21041192 0.96 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL28351994 0.96 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL9075694 0.88 HTT (0.56) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL9075691 0.88 HTT (0.56) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL8696499 0.80 LTA4H (0.42) ALDH1A1MEN1KMT2AHTR2CHTR2B
SCHEMBL13694086 0.80 POLB (0.53) ALDH1A1MEN1KMT2AGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086438-A1 PRODRUGS OF NEUROSTEROID ANALOGS AND USES THEREOF EMORY UNIVERSITY (US) 2023-05-19 WO disclosed
US-7649011-B2 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction CHEMOCENTRYX, INC. (US) 2010-01-19 US disclosed
WO-2008087611-A2 PYRROLIDINE- AND PIPERIDINE- BIS-AMIDE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2008-07-24 WO disclosed